2023
DOI: 10.1016/j.pharmthera.2023.108454
|View full text |Cite
|
Sign up to set email alerts
|

Regulatory lipid vicinal diols counteract the biological activity of epoxy fatty acids and can act as biomarkers and mechanisms for disease progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 83 publications
0
1
0
Order By: Relevance
“…In rodent studies, sEHIs have shown promising results for controlling various inflammatory diseases, such as hypertension, atherosclerosis, diabetes, COPD, liver regeneration, fibrosis, sepsis, asthma, subarachnoid hemorrhage, arthritis, and neuropathic pain ( 27 , 41 , 57 , 96 104 ). Thus, sEH is a critical cause of and biomarker for inflammation in many systems ( 40 , 50 , 53 , 84 , 99 , 105 107 ). The human sEHI EC5026 is in clinical development as an analgesic for neuropathic pain as a nonaddictive opioid alternative ( 42 ).…”
Section: Discussionmentioning
confidence: 99%
“…In rodent studies, sEHIs have shown promising results for controlling various inflammatory diseases, such as hypertension, atherosclerosis, diabetes, COPD, liver regeneration, fibrosis, sepsis, asthma, subarachnoid hemorrhage, arthritis, and neuropathic pain ( 27 , 41 , 57 , 96 104 ). Thus, sEH is a critical cause of and biomarker for inflammation in many systems ( 40 , 50 , 53 , 84 , 99 , 105 107 ). The human sEHI EC5026 is in clinical development as an analgesic for neuropathic pain as a nonaddictive opioid alternative ( 42 ).…”
Section: Discussionmentioning
confidence: 99%